Which ETFs own BLISSGVS.BO?
Bliss GVS Pharma Limited · Healthcare · Drug Manufacturers - Specialty & Generic · IN — 8 ETFs hold it, worth $2.9M across 425.68K shares.
Holdings as of Oct 13, 2026 · portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | AVEE Avantis Emerging Markets Small Cap… | 0.02% | 5.01K | $34.6K | $139.8M | Emerging Markets | -0.40% | |
| 2 | DFEV Dimensional - Emerging Markets Value ETF | 0.01% | 42.63K | $298.1K | $2.19B | Emerging Markets | -0.31% | |
| 3 | AVXC Avantis Emerging Markets ex-China… | 0.01% | 6.69K | $46.2K | $468.7M | Emerging Markets | -0.50% | |
| 4 | DFEM Dimensional - Emerging Markets Core… | 0.01% | 83.79K | $585.9K | $9.67B | Emerging Markets | -0.53% | |
| 5 | AVEM Avantis Emerging Markets Equity ETF | 0.01% | 244.34K | $1.7M | $28.41B | Emerging Markets | -0.48% | |
| 6 | DFSE Dimensional Emerging Markets… | 0.00% | 4.23K | $29.6K | $642.7M | Emerging Markets | -0.33% | |
| 7 | DFAE Dimensional - Emerging Core Equity… | 0.00% | 38.85K | $271.7K | $10.11B | Emerging Markets | -0.46% | |
| 8 | DEXC Dimensional - Emerging Markets ex China… | 0.00% | 136 | $938.22 | $299.1M | Emerging Markets | -0.85% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.